XML 17 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Net revenue $ 39,668 $ 66,326 $ 109,811 $ 166,268
Cost of good sold 20,085 36,135 56,236 81,118
Gross profit 19,583 30,191 53,575 85,150
Operating expenses:        
Sales and distribution 20,921 33,792 61,704 88,632
Research and development 852 1,706 3,808 4,582
General and administrative 4,326 10,369 16,566 29,481
Impairment loss on goodwill 0 90,921 0 119,941
Impairment loss on intangibles 0 3,118 39,445 3,118
Change in fair value of contingent earn-out liabilities 0 (774) 0 (5,240)
Total operating expenses 26,099 139,132 121,523 240,514
Operating loss (6,516) (108,941) (67,948) (155,364)
Interest expense, net 359 904 1,076 2,043
Gain on extinguishment of seller note 0 0 0 (2,012)
Loss on initial issuance of equity 0 12,834 0 18,669
Change in fair value of warrant liability (567) (5,528) (2,410) 2,365
Other (income) expense, net (128) (174) 101 (199)
Loss before income taxes (6,180) (116,977) (66,715) (176,230)
Provision (benefit) for income taxes 90 (75) 142 (243)
Net loss $ (6,270) $ (116,902) $ (66,857) $ (175,987)
Net loss per share, basic and diluted (in dollars per share) $ (0.08) $ (1.81) $ (0.86) $ (2.78)
Weighted-average number of shares outstanding, basic and diluted (in shares) 79,022,467 64,648,650 77,801,774 63,397,196